Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Serina Therapeutics, Inc. (SER) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Serina Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1708599.
Total stock buying since 2018: $734,174.
Total stock sales since 2018: $683,399.
Total stock option exercises since 2018: $4,994,575.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 112,674 | $683,399 | 112,674 | $6,757 |
| 2024 | 93,996 | $718,730 | 0 | $0 | 377,865 | $4,987,818 |
| 2023 | 0 | $0 | 0 | $0 | 3,125 | $0 |
| 2022 | 0 | $0 | 0 | $0 | 12,500 | $0 |
| 2021 | 0 | $0 | 0 | $0 | 12,500 | $0 |
| 2020 | 0 | $0 | 0 | $0 | 21,875 | $0 |
| 2019 | 19,000 | $0 | 0 | $0 | 0 | $0 |
| 2018 | 4,000 | $15,444 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 62,978 | $411,010 | 62,978 | $3,776 |
| 2025-07 | 0 | $0 | 43,196 | $234,819 | 43,196 | $2,591 |
| 2025-06 | 0 | $0 | 6,500 | $37,570 | 6,500 | $390 |
| 2024-12 | 3,866 | $17,744 | 0 | $0 | 0 | $0 |
| 2024-09 | 21,525 | $133,921 | 0 | $0 | 0 | $0 |
| 2024-08 | 36,319 | $258,919 | 0 | $0 | 0 | $0 |
| 2024-06 | 7,600 | $70,900 | 0 | $0 | 377,865 | $4,987,818 |
| 2024-05 | 24,686 | $237,246 | 0 | $0 | 0 | $0 |
| 2023-03 | 0 | $0 | 0 | $0 | 3,125 | $0 |
| 2022-12 | 0 | $0 | 0 | $0 | 3,125 | $0 |
| 2022-09 | 0 | $0 | 0 | $0 | 3,125 | $0 |
| 2022-06 | 0 | $0 | 0 | $0 | 3,125 | $0 |
| 2022-03 | 0 | $0 | 0 | $0 | 3,125 | $0 |
| 2021-12 | 0 | $0 | 0 | $0 | 3,125 | $0 |
| 2021-09 | 0 | $0 | 0 | $0 | 3,125 | $0 |
| 2021-06 | 0 | $0 | 0 | $0 | 3,125 | $0 |
| 2021-03 | 0 | $0 | 0 | $0 | 3,125 | $0 |
| 2020-12 | 0 | $0 | 0 | $0 | 3,125 | $0 |
| 2020-09 | 0 | $0 | 0 | $0 | 3,125 | $0 |
| 2020-06 | 0 | $0 | 0 | $0 | 3,125 | $0 |
| 2020-03 | 0 | $0 | 0 | $0 | 12,500 | $0 |
| 2019-08 | 19,000 | $0 | 0 | $0 | 0 | $0 |
| 2018-12 | 4,000 | $15,444 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-26 | Moreadith Randall (Chief Scientific Officer) | Sale | 45,632 | 7.01 | 319,880 |
| 2025-08-26 | Moreadith Randall (Chief Scientific Officer) | Option Ex | 45,632 | .06 | 2,737 |
| 2025-08-25 | Moreadith Randall (Chief Scientific Officer) | Sale | 2,042 | 5.65 | 11,537 |
| 2025-08-25 | Moreadith Randall (Chief Scientific Officer) | Option Ex | 2,042 | .06 | 122 |
| 2025-08-20 | Moreadith Randall (Chief Scientific Officer) | Sale | 2,077 | 5.10 | 10,592 |
| 2025-08-20 | Moreadith Randall (Chief Scientific Officer) | Option Ex | 2,077 | .06 | 124 |
| 2025-08-18 | Moreadith Randall (Chief Scientific Officer) | Sale | 2,227 | 5.25 | 11,691 |
| 2025-08-18 | Moreadith Randall (Chief Scientific Officer) | Option Ex | 2,227 | .06 | 133 |
| 2025-08-12 | Moreadith Randall (Chief Scientific Officer) | Sale | 5,500 | 5.25 | 28,875 |
| 2025-08-12 | Moreadith Randall (Chief Scientific Officer) | Option Ex | 5,500 | .06 | 330 |
| 2025-08-04 | Moreadith Randall (Chief Scientific Officer) | Sale | 5,500 | 5.17 | 28,435 |
| 2025-08-04 | Moreadith Randall (Chief Scientific Officer) | Option Ex | 5,500 | .06 | 330 |
| 2025-07-29 | Moreadith Randall (Chief Scientific Officer) | Sale | 4,196 | 6.50 | 27,274 |
| 2025-07-29 | Moreadith Randall (Chief Scientific Officer) | Option Ex | 4,196 | .06 | 251 |
| 2025-07-28 | Moreadith Randall (Chief Scientific Officer) | Sale | 6,500 | 5.89 | 38,285 |
| 2025-07-28 | Moreadith Randall (Chief Scientific Officer) | Option Ex | 6,500 | .06 | 390 |
| 2025-07-21 | Moreadith Randall (Chief Scientific Officer) | Sale | 6,500 | 5.34 | 34,710 |
| 2025-07-21 | Moreadith Randall (Chief Scientific Officer) | Option Ex | 6,500 | .06 | 390 |
| 2025-07-14 | Moreadith Randall (Chief Scientific Officer) | Sale | 13,000 | 5.01 | 65,130 |
| 2025-07-14 | Moreadith Randall (Chief Scientific Officer) | Option Ex | 13,000 | .06 | 780 |
| 2025-07-07 | Moreadith Randall (Chief Scientific Officer) | Sale | 6,500 | 5.67 | 36,855 |
| 2025-07-07 | Moreadith Randall (Chief Scientific Officer) | Option Ex | 6,500 | .06 | 390 |
| 2025-06-30 | Moreadith Randall (Chief Scientific Officer) | Sale | 6,500 | 5.78 | 37,570 |
| 2025-06-30 | Moreadith Randall (Chief Scientific Officer) | Option Ex | 6,500 | .06 | 390 |
| 2024-12-17 | Bailey Gregory | Buy | 3,866 | 4.59 | 17,744 |
| 2024-09-20 | Bailey Gregory | Buy | 1,137 | 6.03 | 6,851 |
| 2024-09-19 | Bailey Gregory | Buy | 11,679 | 6.11 | 71,382 |
| 2024-09-18 | Bailey Gregory | Buy | 2,709 | 6.23 | 16,874 |
| 2024-09-12 | Mintz Steven | Buy | 6,000 | 6.47 | 38,814 |
| 2024-08-20 | Bailey Gregory | Buy | 1,776 | 8.25 | 14,652 |
| 2024-08-19 | Bailey Gregory | Buy | 6,400 | 7.93 | 50,758 |
| 2024-08-16 | Bailey Gregory | Buy | 6,400 | 7.31 | 46,777 |
| 2024-08-15 | Mintz Steven | Buy | 8,943 | 6.59 | 58,925 |
| 2024-08-15 | Bailey Gregory | Buy | 6,400 | 6.65 | 42,579 |
| 2024-08-14 | Bailey Gregory | Buy | 6,400 | 7.07 | 45,228 |
| 2024-06-25 | Mintz Steven | Buy | 2,600 | 9.00 | 23,400 |
| 2024-06-21 | Mintz Steven | Buy | 5,000 | 9.50 | 47,500 |
| 2024-06-06 | Juvenescence Ltd | Option Ex | 377,865 | 13.20 | 4,987,818 |
| 2024-05-28 | Bailey Gregory | Buy | 9,019 | 9.50 | 85,680 |
| 2024-05-23 | Bailey Gregory | Buy | 2,371 | 9.50 | 22,524 |
| 2024-05-21 | Mintz Steven | Buy | 9,151 | 9.88 | 90,366 |
| 2024-05-21 | Bailey Gregory | Buy | 916 | 9.50 | 8,702 |
| 2024-05-20 | Mintz Steven | Buy | 2,675 | 9.45 | 25,265 |
| 2024-05-17 | Mintz Steven | Buy | 554 | 8.50 | 4,709 |
| 2023-03-11 | West Michael D (Chief Executive Officer) | Option Ex | 3,125 | .00 | 0 |
| 2022-12-11 | West Michael D (Chief Executive Officer) | Option Ex | 3,125 | .00 | 0 |
| 2022-09-11 | West Michael D (Chief Executive Officer) | Option Ex | 3,125 | .00 | 0 |
| 2022-06-11 | West Michael D (Chief Executive Officer) | Option Ex | 3,125 | .00 | 0 |
| 2022-03-11 | West Michael D (Chief Executive Officer) | Option Ex | 3,125 | .00 | 0 |
| 2021-12-11 | West Michael D (Chief Executive Officer) | Option Ex | 3,125 | .00 | 0 |
| 2021-09-11 | West Michael D (Chief Executive Officer) | Option Ex | 3,125 | .00 | 0 |
| 2021-06-11 | West Michael D (Chief Executive Officer) | Option Ex | 3,125 | .00 | 0 |
| 2021-03-11 | West Michael D (Chief Executive Officer) | Option Ex | 3,125 | .00 | 0 |
| 2020-12-11 | West Michael D (Chief Executive Officer) | Option Ex | 3,125 | .00 | 0 |
| 2020-09-11 | West Michael D (Chief Executive Officer) | Option Ex | 3,125 | .00 | 0 |
| 2020-06-11 | West Michael D (Chief Executive Officer) | Option Ex | 3,125 | .00 | 0 |
| 2020-03-11 | West Michael D (Chief Executive Officer) | Option Ex | 12,500 | .00 | 0 |
| 2019-08-13 | Juvenescence Ltd (10% Owner) | Buy | 19,000 | .00 | 0 |
| 2018-12-10 | West Michael D (Chief Executive Officer) | Buy | 4,000 | 3.86 | 15,444 |
Insider trading activities including stock purchases, stock sales, and option exercises of SER listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Serina Therapeutics, Inc. (symbol SER, CIK number 1708599) see the Securities and Exchange Commission (SEC) website.